Biohaven Ltd.

BHVN | NYSE

Price Alert Chart Builder DCF Calculator

$14.48

+$0.26 (+1.83%)

Sep 22, 2026, 11:09 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.14B

Enterprise Value $2.17B

Beta 3.17

Average Volume 2.83M

Shares Outstanding (Diluted) 150.64M

Shares Change YoY 47.15%

Institutional Ownership 96.25%

Exchange NYSE

ISIN VGG1110E1079

Price Performance

Price Change 1M 1.1%

Price Change 3M -3.8%

Price Change 6M 65.2%

Price Change YTD 31.2%

Price Change 1Y -4.2%

Price Change 3Y -16.0%

Price Change 5Y 94.8%

1M CAGR (ann.) -3.0%

1Y CAGR (ann.) -8.4%

5Y CAGR (ann.) N/A

All-Time CAGR 18.1%

Valuation

PE Ratio -3.06

Forward PE N/A

PEG Ratio -0.06

Forward PEG 0.37

PS Ratio N/A

Forward PS 46.90

PB Ratio 175.17

P/FCF Ratio -4.18

P/Adj. FCF Ratio -3.58

P/OCF Ratio -4.19

EV/Sales N/A

EV/EBIT -3.70

EV/EBITDA -3.77

EV/FCF -4.23

Earnings Yield -32.6%

FCF Yield -23.9%

Adj. FCF Yield -27.9%

Financial Health

Net Debt $24.5M

Total Debt $292.37M

Cash & Short-Term Investments $267.87M

Total Assets $370.74M

Current Ratio 4.73

Quick Ratio 4.73

Debt / Equity Ratio 24.30

Debt / EBITDA -0.51

Debt / FCF -0.57

OCF / Debt -1.75

Interest Coverage 0.00

Altman Z-Score -9.76

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -16.8%

Returns

Return on Assets -158.3%

Return on Equity -1328.9%

Return on Invested Capital -181.4%

Return on Capital Employed -184.2%

Return on Tangible Assets -167.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 31.5%

EPS CAGR 5Y 16.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y -2.4%

FCF CAGR 5Y -20.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 25

EPS Growth Next 3Y 25.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$0.61

EPS Growth Est (next Q) -62.8%

Revenue Est (next Q) $70M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $20

Price Target Upside 40.6%

Cash Flow

Operating Cash Flow $-511.4M

Free Cash Flow $-511.87M

Adj. Free Cash Flow $-597.81M

FCF Per Share -$3.40

OCF Per Share -$3.39

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-2.07M

Operating Income $-567.44M

EBITDA $-574.94M

Net Income $-586.84M

EPS (Diluted) -$4.64

Revenue / Employee N/A

Profit / Employee $-2.14M

Employees 274